Bronchodilators are important agents in the treatment of asthma and chronic obstructive airways disease. Beta agonists, theophyllines, and antimuscarinic agents are the main drugs in current use, but others are under investigation. Although other actions may be important, these drugs produce bronchodilation either by a direct effect on airway smooth muscle or by inhibiting neural pathways. As our understanding of airway smooth muscle relaxant mechanisms increases, new therapeutic possibilities are being realised. Several recent findings contradict established dogma -for example, the assumption that ; agonists and theophyllines act solely via cyclic adenosine monophosphate (cAMP)-linked intracellular pathways has been questioned and studies with atrial natriuretic peptide and nitrates suggest that cyclic guanosine monophosphate (cGMP) may be an important relaxant second messenger. The role of potassium channel activators is being explored with the development of drugs which relax airway smooth muscle by a direct action on cell membrane ion channels. In this review we discuss what is known of the likely mechanisms of action of the airway smooth muscle
Respiratory Medicine relaxants in current use and their effects on Unit, City Hospital, calcium homeostasis, and suggest how de- Role of calcium in relaxation of airway smooth muscle The drugs in current use cause relaxation of airway smooth muscle by stimulating a cyclic nucleotide second messenger system, predominantly cAMP and cGMP, by inhibiting the breakdown of cyclic nucleotides or by a direct action on cell membrane ion channels or transporters (table 1, fig 1) . Since the relation between an increase in intracellular calcium and contraction is well established, it is generally assumed that relaxation is preceded by a fall in intracellular calcium, although relatively few studies have investigated this. A fall in intracellular calcium (measured by aequorin luminescence)' accompanied isoprenaline-induced relaxation in canine trachealis contracted with 5-hydroxytryptamine or cholinergic agonists and, since the fall in intracellular calcium correlated strongly with the reduction in tension, it was thought to be responsible. A fall in cellular calcium was also seen in cAMP-mediated relaxation in canine airway smooth muscle2 and in cGMP-mediated relaxation in canine and bovine airway smooth muscle. 34 There was no fall in intracellular calcium in response to e agonist in bovine tracheal smooth muscle in one study,5 and in some studies increases in intracellular calcium in response to ,B agonists have been seen as a result of calcium influx through membrane channels under resting conditions.36 The inconsistencies seen in these studies may be due to the fact that the experiments which failed to show a reduction in calcium were carried out at 22°C when many intracellular processes, including Na +/K+ ATPase, would be inhibited. On balance it seems likely that a fall in intracellular calcium is associated with relaxation in the same way that an increase in intracellular calcium is associated with contraction. and cGMP converting them to their inactive 5'-nucleotide metabolites 5'-AMP and 5'-GMP. Theophylline and other xanthine derivatives cause airway smooth muscle relaxation in vitro and bronchodilatation in vivo, and although they may have other mechanisms of action, phosphodiesterase (PDE) inhibition appears to be important for smooth muscle relaxation.7' Theophylline has been shown to relax smooth muscle from several species including man when contracted with a wide range of spasmogens in vitro,72 although it is some 1000 times less potent than isoprenaline in relaxing human bronchi contracted by moderate doses of carbachol.73 Theophylline is a rather nonselective inhibitor of tissue phosphodiesterases and this is one factor underlying its narrow therapeutic index.
Recent studies have identified at least seven classes of PDE isoenzymes, each of which has several isoforms (table 2). These isoenzymes vary in their tissue distribution and their ability to break down cAMP and cGMP.7475 Airway smooth muscle contains several PDE isoenzymes in most species and in human airway smooth muscle types III, IV and, to a lesser extent, V are important for relaxation. 76 
